Dr. Heller received her medical degree from Columbia University and a Masters of Business Administration from The University of Chicago. She has extensive professional experience within the pharmaceutical and healthcare industries and academic medical centers. As the Chief Scientific Officer at the Crohn’s and Colitis Foundation, Dr. Heller is responsible for all mission-related activities, including the research efforts and patient and provider support and education programs. She previously worked for Weill Cornell Medical College, where she was Associate Dean of Intercampus and Industry Initiatives. In that role, Dr. Heller implemented plans to promote interdisciplinary collaborations between the medical school and Cornell University faculties, facilitated the development of an NIH-funded intercampus center, promoted collaborative research projects with industry partners, and managed the intercampus pilot grant program. Prior to Weill Cornell Medical College, she was at Athena Healthcare Consulting, working with industry and academic centers regarding new product opportunities, new drug development, and clinical and translational research. While there, she developed Models of Care, a health care information series that identified and described best practices in disease management. In addition, Dr. Heller has experience in pharmaceutical drug development, including design and implementation of clinical development plans and involvement in new drug applications resulting in drug approvals. She has been published in more than 20 publications and is the recipient of the “Best Journal Article on Disease Management” honor.